Eilon D. Kirson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eilon D. Kirson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eilon D. Kirson. Eilon D. Kirson is Chief Scientific Officer in Novocure Ltd ($NVCR) and Chief Science Officer in Novocure Ltd ($NVCR).
Latest Insider Trading Transactions of Eilon D. Kirson
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 0.00 | 6,945 | 0 | 13,888 | |
| Mar 01 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 52.90 | 6,945 | 367,391 | 152,408 | 145.5 K to 152.4 K (+4.77 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 14.37 | 68,813 | 988,843 | 66,522 | |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 14.37 | 100,000 | 1,437,000 | 135,335 | |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 45.25 | 68,813 | 3,113,788 | 109,063 | 177.9 K to 109.1 K (-38.69 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 14.37 | 68,813 | 988,843 | 177,876 | 109.1 K to 177.9 K (+63.09 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 45.11 | 100,000 | 4,511,000 | 109,063 | 209.1 K to 109.1 K (-47.83 %) |
| Jan 18 2019 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 14.37 | 100,000 | 1,437,000 | 209,063 | 109.1 K to 209.1 K (+91.69 %) |
| Jul 10 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Grant | A | 17.26 | 1,231 | 21,241 | 109,063 | 107.8 K to 109.1 K (+1.14 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 11.46 | 37,500 | 429,750 | 37,500 | |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 14.37 | 30,750 | 441,878 | 235,335 | |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 11.46 | 37,500 | 429,750 | 107,832 | 70.3 K to 107.8 K (+53.32 %) |
| Jun 15 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 14.37 | 30,750 | 441,878 | 70,332 | 39.6 K to 70.3 K (+77.69 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.15 | 68,250 | 487,988 | 204,750 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.48 | 59,130 | 442,292 | 0 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 7.03 | 218,781 | 1,538,030 | 0 | |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 31.74 | 4,131 | 131,118 | 39,582 | 43.7 K to 39.6 K (-9.45 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 30.26 | 1,800 | 54,468 | 43,713 | 45.5 K to 43.7 K (-3.95 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 29.36 | 114,934 | 3,374,462 | 45,513 | 160.4 K to 45.5 K (-71.63 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.15 | 68,250 | 487,988 | 160,447 | 92.2 K to 160.4 K (+74.03 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.48 | 59,130 | 442,292 | 92,197 | 33.1 K to 92.2 K (+178.82 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 28.60 | 225,296 | 6,443,466 | 33,067 | 258.4 K to 33.1 K (-87.20 %) |
| Jun 06 2018 | NVCR | NovoCure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 7.03 | 218,781 | 1,538,030 | 258,363 | 39.6 K to 258.4 K (+552.73 %) |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 3.44 | 70,956 | 244,089 | 0 | |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 3.44 | 76,869 | 264,429 | 0 | |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 24.00 | 70,956 | 1,702,944 | 39,582 | 110.5 K to 39.6 K (-64.19 %) |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 3.44 | 70,956 | 244,089 | 110,538 | 39.6 K to 110.5 K (+179.26 %) |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 24.00 | 76,869 | 1,844,856 | 39,582 | 116.5 K to 39.6 K (-66.01 %) |
| Apr 20 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 3.44 | 76,869 | 264,429 | 116,451 | 39.6 K to 116.5 K (+194.20 %) |
| Mar 01 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | A | 0.00 | 20,833 | 0 | 20,833 | |
| Mar 01 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | A | 21.15 | 152,068 | 3,216,238 | 152,068 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Option Exercise | M | 0.00 | 36,401 | 0 | 72,799 | |
| Feb 26 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Buy | M | 21.55 | 36,401 | 784,442 | 39,582 | 3.2 K to 39.6 K (+1,144.33 %) |
| Jan 16 2018 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 22.00 | 25,320 | 557,126 | 3,181 | 28.5 K to 3.2 K (-88.84 %) |
| Nov 08 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 22.00 | 9,100 | 200,200 | 28,501 | 37.6 K to 28.5 K (-24.20 %) |
| Nov 06 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 22.00 | 3,100 | 68,200 | 37,601 | 40.7 K to 37.6 K (-7.62 %) |
| Nov 06 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 22.00 | 300 | 6,600 | 40,701 | 41 K to 40.7 K (-0.73 %) |
| Sep 27 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | D | 22.03 | 1,900 | 41,865 | 63,270 | 65.2 K to 63.3 K (-2.92 %) |
| Sep 15 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | D | 22.03 | 2,500 | 55,080 | 65,170 | 67.7 K to 65.2 K (-3.69 %) |
| Sep 15 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | D | 22.01 | 46,872 | 1,031,765 | 67,670 | 114.5 K to 67.7 K (-40.92 %) |
| Jul 07 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | D | 18.14 | 111,361 | 2,020,534 | 114,542 | 225.9 K to 114.5 K (-49.30 %) |
| Jul 07 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Grant | A | 6.67 | 3,181 | 21,227 | 225,903 | 222.7 K to 225.9 K (+1.43 %) |
| Jun 22 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 16.78 | 66,361 | 1,113,206 | 222,722 | 289.1 K to 222.7 K (-22.96 %) |
| Jun 21 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.06 | 15,000 | 225,885 | 289,083 | 304.1 K to 289.1 K (-4.93 %) |
| Jun 15 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.01 | 9,044 | 135,769 | 304,083 | 313.1 K to 304.1 K (-2.89 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.08 | 5,956 | 89,828 | 313,127 | 319.1 K to 313.1 K (-1.87 %) |
| Jun 13 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Science Offic ... | Sell | S | 15.02 | 15,000 | 225,225 | 319,083 | 334.1 K to 319.1 K (-4.49 %) |
| Feb 24 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Option Exercise | A | 0.00 | 109,200 | 0 | 109,200 | |
| Feb 24 2017 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Option Exercise | A | 7.15 | 273,000 | 1,951,950 | 273,000 | |
| Dec 06 2016 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Option Exercise | M | 0.17 | 156,073 | 26,532 | 0 | |
| Dec 06 2016 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Buy | M | 0.17 | 156,073 | 26,532 | 334,083 | 178 K to 334.1 K (+87.68 %) |
| Feb 26 2016 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Option Exercise | A | 11.46 | 75,000 | 859,500 | 75,000 | |
| Apr 18 2016 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Option Exercise | M | 0.17 | 29,565 | 5,026 | 0 | |
| Apr 18 2016 | NVCR | Novocure Ltd | Kirson Eilon D. | Chief Scientific O ... | Buy | M | 0.17 | 29,565 | 5,026 | 178,010 | 148.4 K to 178 K (+19.92 %) |
Page: 1